Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United
States. HCV is transmitted primarily through parenteral exposures to infectious blood or …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

Importance Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in
the US and a leading cause of complications from chronic liver disease. HCV is associated …

In the United States, an estimated 4.1 million persons have been infected with hepatitis C
virus (HCV), of whom an estimated 3.2 (95% confidence interval [CI]= 2.7–3.9) million are …

Abstract The Infectious Diseases Society of America and the American Association for the
Study of Liver Diseases have collaboratively developed evidence-based guidance …

Testing and diagnosis of hepatitis C virus (HCV) infection is the gateway for access to both
treatment and prevention services, and crucial for an effective hepatitis epidemic response …

Introduction: Hepatitis C is a leading cause of death from liver disease in the United States.
Acute hepatitis C infection is often asymptomatic, and> 50% of cases will progress to chronic …

Chinese translation Description: Update of the 2004 US Preventive Services Task Force
(USPSTF) recommendation on screening for and treatment of hepatitis C virus (HCV) …

Abstract Background The US Centers for Disease Control and Prevention and the US
Preventive Services Task Force recommend one-time hepatitis C virus (HCV) testing for …

The pace of hepatitis C virus (HCV) drug development in recent years has accelerated
dramatically. For patients to benefit from these impressive advances, practitioners need …